Skip to content

ELISA-VIDITEST anti-TBEV IgG and IgG avidity

by VIDIA spol. s r.o. Czech Republic EUDAMED

Ref ODZ-170Model ELISA-VIDITEST anti-TBEV IgG and IgG avidity

EMDN W0105040612

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-28594036041701 Basic UDI-DIDate23 Jun 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/IVDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Model / Reference
ELISA-VIDITEST anti-TBEV IgG and IgG avidity, ODZ-170
Primary DI / UDI-DI
28594036041701
Basic UDI-DI
B-28594036041701
EMDN Code
W0105040612 Fsme virus
Device Class
Class IVD General
Market of Registration
Czechia

Manufacturer details

EUDAMED SRN
CZ-MF-000036964

Other devices from VIDIA spol. s r.o.

See all devices from VIDIA spol. s r.o. →

Properties & raw data

Show properties, registry sources and raw records
  • Human Tissues
  • Microbial Substances
  • Professional Testing
Other properties (7)
  • Sterile: No
  • Animal Tissues: No
  • Reagent: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No

Sources (1)

  • EUDAMED b6291327-ae20-472e-86a1-f5cd62db3fcc 61 fields · synced 24 Oct 2026